Wednesday, June 29, 2011

FDA panel rejects Avastin for breast cancer use

SILVER SPRING, Maryland (Reuters) - Health advisers delivered a blow to Roche Holding on Wednesday, voting to reject the use of Roche Holding drug Avastin for breast cancer while the Swiss drugmaker conducts more studies.

doctor oz website

No comments:

Post a Comment